Hurlow Wealth Management Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,616
Closed -$202K 125
2024
Q4
$202K Sell
7,616
-4
-0.1% -$108 0.06% 120
2024
Q3
$221K Sell
7,620
-421
-5% -$12.3K 0.07% 113
2024
Q2
$225K Buy
8,041
+296
+4% +$8.15K 0.08% 110
2024
Q1
$215K Sell
7,745
-1,746
-18% -$48.4K 0.08% 110
2023
Q4
$273K Sell
9,491
-10,356
-52% -$313K 0.1% 88
2023
Q3
$658K Sell
19,847
-45
-0.2% -$1.59K 0.29% 42
2023
Q2
$730K Buy
19,892
+52
+0.3% +$2.02K 0.31% 40
2023
Q1
$809K Sell
19,840
-21
-0.1% -$907 0.37% 38
2022
Q4
$1.02M Buy
19,861
+1,136
+6% +$54.5K 0.53% 33
2022
Q3
$819K Hold
18,725
0.48% 34
2022
Q2
$982K Hold
18,725
0.57% 31
2022
Q1
$969K Sell
18,725
-632
-3% -$32.8K 0.59% 30
2021
Q4
$695K Buy
19,357
+632
+3% +$31.3K 0.55% 30
2021
Q3
$805K Sell
18,725
-388
-2% -$17.2K 0.48% 32
2021
Q2
$748K Sell
19,113
-2,979
-13% -$116K 0.49% 32
2021
Q1
$800K Buy
22,092
+217
+1% +$7.71K 0.58% 31
2020
Q4
$805K Buy
21,875
+2,139
+11% +$78.5K 0.63% 27
2020
Q3
$687K Sell
19,736
-68
-0.3% -$2.38K 0.63% 27
2020
Q2
$662K Hold
19,804
0.64% 27
2020
Q1
$676K Buy
19,804
+969
+5% +$33K 0.72% 29
2019
Q4
$724K Hold
18,835
0.71% 28
2019
Q3
$649K Hold
18,835
0.69% 30
2019
Q2
$770K Hold
18,835
0.81% 27
2019
Q1
$726K Hold
18,835
0.78% 27
2018
Q4
$706K Buy
+18,835
New +$782K 0.85% 28

Other funds holding PFE

Hurlow Wealth Management Group's PFE Position: Q1 2025 in Review

Hurlow Wealth Management Group sold out of Pfizer (PFE) in Q1 2025, closing a stake of 7,616 shares — an estimated $202K sold.

Hurlow Wealth Management Group first reported a position in PFE in Q4 2018 and held it in 25 quarters. The position peaked at $1.02M in Q4 2022. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Hurlow Wealth Management Group reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Hurlow Wealth Management Group sold 7,616 Pfizer shares in Q1 2025, an estimated $202K.
  • Hurlow Wealth Management Group first reported a position in Pfizer in Q4 2018 and held it in 25 quarters.
  • Hurlow Wealth Management Group's Pfizer position peaked at $1.02M in Q4 2022.
  • 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Hurlow Wealth Management Group's 13F filing for Q1 2025, filed 8 May 2025.